255 related articles for article (PubMed ID: 25405881)
1. Celebrating 40 years of progress in bone marrow transplantation: a report from the 40th Annual Meeting of the European Society for Blood and Marrow Transplantation.
Pagano L; Lyon S
Future Microbiol; 2014; 9(10):1117-21. PubMed ID: 25405881
[TBL] [Abstract][Full Text] [Related]
2. Antifungal prophylaxis: why, what and how?
Lyon S
Future Microbiol; 2016; 11(1):11-5. PubMed ID: 26674314
[TBL] [Abstract][Full Text] [Related]
3. Invasive fungal infections: managing the continuum of risk in HCT patients.
Duarte RF; Lyon S
Future Microbiol; 2017 Aug; 12():843-846. PubMed ID: 28685597
[TBL] [Abstract][Full Text] [Related]
4. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
Salavert M
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S149-53. PubMed ID: 19013340
[TBL] [Abstract][Full Text] [Related]
5. A multidisciplinary approach to managing invasive fungal disease. Introduction and aims.
Donnelly JP
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii3-4. PubMed ID: 24319773
[No Abstract] [Full Text] [Related]
6. Managing invasive fungal disease in immunocompromised patients.
Maertens J; Bryan J
Future Microbiol; 2010 Dec; 5(12):1775-9. PubMed ID: 21155660
[TBL] [Abstract][Full Text] [Related]
7. A multidisciplinary team approach to the management of patients with suspected or diagnosed invasive fungal disease.
Ben-Ami R; Halaburda K; Klyasova G; Metan G; Torosian T; Akova M
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii25-33. PubMed ID: 24155143
[TBL] [Abstract][Full Text] [Related]
8. Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects.
Akan H; Antia VP; Kouba M; Sinkó J; Tănase AD; Vrhovac R; Herbrecht R
J Antimicrob Chemother; 2013 Nov; 68 Suppl 3():iii5-16. PubMed ID: 24155144
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis and treatment of invasive fungal diseases in allogeneic stem cell transplantation: results of a consensus process by Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
Girmenia C; Barosi G; Aversa F; Bacigalupo A; Barbui T; Baronciani D; Bosi A; Candoni A; Locasciulli A; Locatelli F; Menichetti F; Musso M; Viscoli C; Rambaldi A
Clin Infect Dis; 2009 Oct; 49(8):1226-36. PubMed ID: 19772390
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of fungal infections in children and adolescents with cancer].
Groll AH; Ritter J; Müller FM
Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
[TBL] [Abstract][Full Text] [Related]
11. Managing invasive fungal infection in hematopoietic stem-cell transplantation.
Sinkó J; Bryan J
Future Microbiol; 2010 Sep; 5(9):1309-14. PubMed ID: 20860477
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in antifungal prevention and treatment.
Groll AH; Tragiannidis A
Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
[TBL] [Abstract][Full Text] [Related]
13. Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol.
Castagnola E; Bucci B; Montinaro E; Viscoli C
Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():97-106. PubMed ID: 8932808
[TBL] [Abstract][Full Text] [Related]
14. Posaconazole is not superior to itraconazole for fungal prophylaxis in allogeneic blood and marrow transplantation.
Mossad SB
Bone Marrow Transplant; 2012 Oct; 47(10):1379; author reply 1380. PubMed ID: 22388277
[No Abstract] [Full Text] [Related]
15. Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Chanock SJ; Walsh TJ
Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S15-20. PubMed ID: 8971401
[TBL] [Abstract][Full Text] [Related]
16. Systemic fungal infections: major problems in cancer patients.
Powles RL; Mehta J
Indian J Cancer; 1994 Sep; 31(3):180-4. PubMed ID: 8557296
[TBL] [Abstract][Full Text] [Related]
17. Current practice of antifungal prophylaxis and treatment in immunocompromised children and adults with malignancies: a single centre approach.
Lehrnbecher T; Mousset S; Sörensen J; Böhme A
Mycoses; 2009 Mar; 52(2):107-17. PubMed ID: 18983431
[TBL] [Abstract][Full Text] [Related]
18. [Fungal infections in transplantation patients].
Colomba C; Antinori S
Recenti Prog Med; 2003 Nov; 94(11):516-28. PubMed ID: 14679922
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in the management of invasive fungal infections in hematopoietic stem cell transplant recipients. 34th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), March 30-April 2, 2008, Florence, Italy.
Maertens J; Bryan J
Future Microbiol; 2008 Oct; 3(5):493-6. PubMed ID: 18811232
[No Abstract] [Full Text] [Related]
20. Approach to invasive fungal infection after blood or marrow transplantation.
Wingard JR
Transplant Proc; 2000 Nov; 32(7):1543-4. PubMed ID: 11119826
[No Abstract] [Full Text] [Related]
[Next] [New Search]
